In addition, TGF-β regulates the expression of targets implicated in increased tumor angiogenesis and drug resistance, including programmed death-l and its ligand (PD-L/PD-L1), vascular endothelial growth factor (VEGF), and an immune response regulator, NKG2D [86]. The gene discussed is CD274; the disease is neoplasm.